Hemoperfusion is ineffectual in severe chloroquine poisoning

被引:9
作者
Boereboom, FTJ
Ververs, FFT
Meulenbelt, J
van Dijk, A
机构
[1] Univ Med Ctr Utrecht, Dept Intens Care Clin Toxicol, Div Internal Med & Dermatol, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Div Hosp Pharm, NL-3508 GA Utrecht, Netherlands
[3] Natl Inst Publ Hlth & Environm, Natl Poisons Control Ctr, NL-3720 BA Bilthoven, Netherlands
关键词
intoxication; poisoning; chloroquine; hemoperfusion; intensive care; critical care; toxicokinetics; pharmacokinetics; plasma concentrations; whole blood concentrations;
D O I
10.1097/00003246-200009000-00040
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To study the toxicokinetics in severe chloroquine poisoning, and to evaluate the efficacy of hemoperfusion. Design:Case report on one observation. Setting: Medical intensive care unit (ICU) of the University Medical Center Utrecht, The Netherlands. Patient History: A previously healthy, 52-yr-old woman ingested 100 tablets containing 100 mg chloroguine base 1 hr before admission. At admission, she was drowsy, agitated, hypotensive, and in respiratory distress. Shortly thereafter, she was resuscitated from cardiac arrest. After hemodynamic and respiratory stabilization, the patient was transferred to the medical ICU. Toxicokinetios Evaluation: During the course of her stay at the ICU, blood samples were taken for the determination of chloroquine and the metabolite desethylchloroquine concentration. Hemoperfusion was started 3.5 hrs after ingestion of the chloroquine tablets. Measurements and Main Results:The following toxicokinetics data during this severe chloroquine poisoning were calculated: apparent volume of the central compartment 181 L, apparent volume of distribution 1137 L., half-life in the distribution phase 6.4 hrs, half-life in the elimination phase 392.8 hrs, and total body clearance 2.01 L/hour, The average extraction ratio during hemoperfusion was 0,07, 0.28, and 0,25, in plasma, erythrocytes and whole blood, respectively. The total amount of chloroquine removed by hemoperfusion was only 480 mg (5.3% of the amount ingested). Simulation of a hemoperfusion session over 5 hrs by using a column with an optimal extraction ratio of 1,0 would have removed 1,816 mg chloroquine, only 18.2% of the amount ingested. This limited contribution of hemoperfusion to the total clearance makes it ineffective. Conclusion: Hemoperfusion is not effective in severe chloroquine poisoning, even when started (relatively) early in the course of the intoxication. Toxicokinetic evaluation of a chloroquine poisoning should be based on the evaluation of plasma and whole blood concentrations.
引用
收藏
页码:3346 / 3350
页数:5
相关论文
共 18 条
  • [1] HPLC METHOD FOR THE DETERMINATION OF CHLOROQUINE AND ITS MAIN METABOLITE IN BIOLOGICAL SAMPLES
    AUGUSTIJNS, P
    VERBEKE, N
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY, 1990, 13 (06): : 1203 - 1213
  • [2] HYPOKALEMIA RELATED TO ACUTE CHLOROQUINE INGESTION
    CLEMESSY, JL
    FAVIER, C
    BORRON, SW
    HANTSON, PE
    VICAUT, E
    BAUD, FJ
    [J]. LANCET, 1995, 346 (8979): : 877 - 880
  • [3] Treatment of acute chloroquine poisoning: A 5-year experience
    Clemessy, JL
    Taboulet, P
    Hoffman, JR
    Hantson, P
    Barriot, P
    Bismuth, C
    Baud, FJ
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (07) : 1189 - 1195
  • [4] Clinical pharmacokinetics and metabolism of chloroquine - Focus on recent advancements
    Ducharme, J
    Farinotti, R
    [J]. CLINICAL PHARMACOKINETICS, 1996, 31 (04) : 257 - 274
  • [5] ELLENHORN MJ, ELLENHORNS MED TOXIC, V285, P97
  • [6] DISPOSITION OF CHLOROQUINE IN MAN AFTER SINGLE INTRAVENOUS AND ORAL DOSES
    GUSTAFSSON, LL
    WALKER, O
    ALVAN, G
    BEERMANN, B
    ESTEVEZ, F
    GLEISNER, L
    LINDSTROM, B
    SJOQVIST, F
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (04) : 471 - 479
  • [7] Heath A, 1982, J Toxicol Clin Toxicol, V19, P1067
  • [8] CLINICAL-FEATURES AND MANAGEMENT OF POISONING DUE TO ANTIMALARIAL-DRUGS
    JAEGER, A
    SAUDER, P
    KOPFERSCHMITT, J
    FLESCH, F
    [J]. MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1987, 2 (04): : 242 - 273
  • [9] KANTOLA I, 1985, BRIT MED J, V290, P1394
  • [10] MCCANN WP, 1975, PEDIATRICS, V55, P536